Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Clear surgical margins as a prognostic indicator for disease recurrence, with no impact on survival rates in patients with myxofibrosarcoma

T. Tomáš, V. Apostolopoulos, L. Pazourek, M. Kubíček, I. Staniczková Zambo, D. Adámková, P. Šlampa, M. Mahdal

. 2024 ; 14 (1) : 12232. [pub] 20240528

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24013849

Myxofibrosarcoma presents an infiltrating growth pattern that results in a high tendency for local recurrence. Clear margin resection is challenging because of microscopic infiltration. The purpose of the present study was to analyze the overall and disease-free survival rates of patients with myxofibrosarcoma and the prognostic factors that determine both survival and disease recurrence. Among the 111 patients included in our study, the 5-year overall survival rate was 65.5%. An age of more than 65 years (hazard ratio [HR] 1.9 [95% confidence interval (CI) 1.4-5.6]; p < 0.001), a tumor size of more than 5 cm (HR 2.8 [95% CI 0.9-8.1]; p = 0.049) and the G3 tumor grade (HR 14.1 [95% CI 2.1-105.0]; p < 0.001) negatively affected overall survival. The 5-year recurrence-free survival rate was 49.4%. R1/R2-type resection (HR 2.4 [95% CI 1.0-5.6]; p = 0.048) had a detrimental effect on tumor recurrence. Clear margins had a positive impact on recurrence-free survival, but did not significantly affect overall patient survival, suggesting that other factors may play a more significant role in determining patient outcomes. A surgical margin of 2 mm was not sufficient to significantly influence the incidence of recurrence. Consequently, a wider surgical margin may be necessary to reduce the risk of myxofibrosarcoma recurrence.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24013849
003      
CZ-PrNML
005      
20240905134211.0
007      
ta
008      
240725s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41598-024-63035-6 $2 doi
035    __
$a (PubMed)38806595
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Tomáš, Tomáš $u First Department of Orthopaedic Surgery, St. Anne's University Hospital, 60200, Brno, Czech Republic $u Faculty of Medicine, Masaryk University, 62500, Brno, Czech Republic
245    10
$a Clear surgical margins as a prognostic indicator for disease recurrence, with no impact on survival rates in patients with myxofibrosarcoma / $c T. Tomáš, V. Apostolopoulos, L. Pazourek, M. Kubíček, I. Staniczková Zambo, D. Adámková, P. Šlampa, M. Mahdal
520    9_
$a Myxofibrosarcoma presents an infiltrating growth pattern that results in a high tendency for local recurrence. Clear margin resection is challenging because of microscopic infiltration. The purpose of the present study was to analyze the overall and disease-free survival rates of patients with myxofibrosarcoma and the prognostic factors that determine both survival and disease recurrence. Among the 111 patients included in our study, the 5-year overall survival rate was 65.5%. An age of more than 65 years (hazard ratio [HR] 1.9 [95% confidence interval (CI) 1.4-5.6]; p < 0.001), a tumor size of more than 5 cm (HR 2.8 [95% CI 0.9-8.1]; p = 0.049) and the G3 tumor grade (HR 14.1 [95% CI 2.1-105.0]; p < 0.001) negatively affected overall survival. The 5-year recurrence-free survival rate was 49.4%. R1/R2-type resection (HR 2.4 [95% CI 1.0-5.6]; p = 0.048) had a detrimental effect on tumor recurrence. Clear margins had a positive impact on recurrence-free survival, but did not significantly affect overall patient survival, suggesting that other factors may play a more significant role in determining patient outcomes. A surgical margin of 2 mm was not sufficient to significantly influence the incidence of recurrence. Consequently, a wider surgical margin may be necessary to reduce the risk of myxofibrosarcoma recurrence.
650    _2
$a lidé $7 D006801
650    _2
$a ženské pohlaví $7 D005260
650    12
$a fibrosarkom $x chirurgie $x patologie $x mortalita $7 D005354
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a senioři $7 D000368
650    12
$a lokální recidiva nádoru $x patologie $7 D009364
650    _2
$a lidé středního věku $7 D008875
650    12
$a resekční okraje $7 D000072662
650    _2
$a prognóza $7 D011379
650    _2
$a dospělí $7 D000328
650    _2
$a míra přežití $7 D015996
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a přežití bez známek nemoci $7 D018572
650    _2
$a retrospektivní studie $7 D012189
655    _2
$a časopisecké články $7 D016428
700    1_
$a Apostolopoulos, Vasileios $u First Department of Orthopaedic Surgery, St. Anne's University Hospital, 60200, Brno, Czech Republic $u Faculty of Medicine, Masaryk University, 62500, Brno, Czech Republic
700    1_
$a Pazourek, Lukáš $u First Department of Orthopaedic Surgery, St. Anne's University Hospital, 60200, Brno, Czech Republic $u Faculty of Medicine, Masaryk University, 62500, Brno, Czech Republic
700    1_
$a Kubíček, Marián $u First Department of Orthopaedic Surgery, St. Anne's University Hospital, 60200, Brno, Czech Republic $u Faculty of Medicine, Masaryk University, 62500, Brno, Czech Republic
700    1_
$a Staniczková Zambo, Iva $u Faculty of Medicine, Masaryk University, 62500, Brno, Czech Republic $u First Pathology Department, St. Anne's University Hospital, 60200, Brno, Czech Republic
700    1_
$a Adámková, Dagmar $u Faculty of Medicine, Masaryk University, 62500, Brno, Czech Republic $u Clinic of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, 60200, Brno, Czech Republic
700    1_
$a Šlampa, Pavel $u Faculty of Medicine, Masaryk University, 62500, Brno, Czech Republic $u Department of Radiation Oncology, Masaryk Memorial Cancer Institute, 60200, Brno, Czech Republic
700    1_
$a Mahdal, Michal $u First Department of Orthopaedic Surgery, St. Anne's University Hospital, 60200, Brno, Czech Republic. michal.mahdal@fnusa.cz $u Faculty of Medicine, Masaryk University, 62500, Brno, Czech Republic. michal.mahdal@fnusa.cz
773    0_
$w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 14, č. 1 (2024), s. 12232
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38806595 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240905134204 $b ABA008
999    __
$a ok $b bmc $g 2143578 $s 1225715
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 14 $c 1 $d 12232 $e 20240528 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
LZP    __
$a Pubmed-20240725

Najít záznam

Citační ukazatele

Možnosti archivace